Stocks to watch: Hewlett-Packard, Transatlantic

The computer maker will report quarterly results after the market closes. Alleghany says it will buy Transatlantic Holdings for $3.4 billion.

By TheStreet Staff Nov 21, 2011 8:42AM

TheStreetBy Joseph Woelfel, TheStreet


Hewlett-Packard (HPQ) will report fiscal-fourth-quarter earnings after the close Monday. The report will be the first under new CEO Meg Whitman, who joined the company in the middle of the quarter. Analysts expect HP to have earned $1.13 a share on revenue of $32.06 billion.


Property and casualty insurer Alleghany (Y) said it will buy reinsurer Transatlantic Holdings (TRH) for $3.4 billion in a cash-and-stock deal. The per-share price of $59.79 is a 10% premium to Transatlantic's Friday closing price of $54.43.


Gilead Sciences (GILD) has agreed to buy Pharmasset  (VRUS) for $137 a share in cash in a deal valued at $11 billion. The transaction price is an 89% premium to Pharmasset's Friday closing price of $72.67.


Tyson Foods (TSN) said its fiscal-fourth-quarter profit fell to $97 million, or 26 cents a share, from $213 million, or 57 cents, a year earlier. The results fell short of the 32-cent profit analysts surveyed by Thomson Reuters expected.


Pfizer (PFE) will pay more than $60 million to settle federal probes into whether it paid bribes to win business outside the U.S., according to The Wall Street Journal. The settlements are expected to be made public by the end of the year, according to the report, published Sunday on the Journal's website. The report cited anonymous sources familiar with the situation.


Western Digital (WDC), the producer of computer-storage technology, said an arbitrator in Minnesota has ruled against the company in a dispute with Seagate Technology (STX) and awarded Seagate $525 million plus interest. Western Digital shares were down 1% to $25.59.


Earnings are also expected from Analog Devices (ADI) and Brocade Communications (BRCD).


Related Articles


Nov 21, 2011 10:24AM
With companies like Gilead, Phizer, Merck I was heavily invested in when I was in my 30's but now that I'm in my 60's in many ways I'm regretful of their medical advancements. I should have died many years ago.
Please help us to maintain a healthy and vibrant community by reporting any illegal or inappropriate behavior. If you believe a message violates theCode of Conductplease use this form to notify the moderators. They will investigate your report and take appropriate action. If necessary, they report all illegal activity to the proper authorities.
100 character limit
Are you sure you want to delete this comment?


Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.



Quotes delayed at least 15 min
Sponsored by:


There’s a problem getting this information right now. Please try again later.
There’s a problem getting this information right now. Please try again later.
Market index data delayed by 15 minutes

[BRIEFING.COM] The stock market finished an upbeat week on a mixed note. The S&P 500 shed less than a point, ending the week higher by 1.3%, while the Dow Jones Industrial Average (+0.1%) cemented a 1.7% advance for the week. High-beta names underperformed, which weighed on the Nasdaq Composite (-0.3%) and the Russell 2000 (-1.3%).

Equity indices displayed strength in the early going with the S&P 500 tagging the 2,019 level during the opening 30 minutes of the action. However, ... More


There’s a problem getting this information right now. Please try again later.
Sponsored by: